Colin P N Dinney

7PUBLICATIONS
30CO-AUTHORS
Molecular targetsGene and molecular therapyPredictive and prognostic markersTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 29, 2024
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer.

Matthew T Campbell, Amishi Y Shah, Pavlos Msaouel

|Aug 12, 2024
The Evolution of Nadofaragene Firadenovec: A Review and the Path Forward.

Alexis R Steinmetz, Sharada Mokkapati, David McConkey

|Apr 13, 2023
The current status of gene therapy in bladder cancer.

Côme Tholomier, Alberto Martini, Sharada Mokkapati

|Mar 04, 2020
TCF21 Promotes Luminal-Like Differentiation and Suppresses Metastasis in Bladder Cancer.

Sharada Mokkapati, Sima P Porten, Vikram M Narayan

|Nov 13, 2019
Adaptive Immune Resistance to Intravesical BCG in Non-Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials.

Max Kates, Andres Matoso, Woonyoung Choi

|Jun 06, 2019
Should chemotherapy still be used to treat all muscle invasive bladder cancer in the "era of immunotherapy"?

Jonathan J Duplisea, Colin P N Dinney

Pageof 2